 MALVERN, Pa., Nov. 10, 2020 GLOBE NEWSWIRE -- TELA Bio, Inc. TELA, a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announced today that the company plans to participate in two upcoming investor conferences. 